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Supplementary Figures 
 
Figure S1. Chromatograms for detection of BSA and the corroles in BSA/corrole 
conjugates, with the reading set at 280 nm for detection of BSA (blue line) and at 414 nm 
for detection of corroles (red line): (a) (2)Sb, (b) (2)Al, (c) (2)Ga,  (d) (2)Mn (e) (2)Fe,  (f) 
(2)Sn, (g) (2)H3 and (h) BSA only. Bioconjugates were formulated as previously 
discussed (Protocol), and BSA was treated under the same conditions but without the 
presence of any corrole. Freeze dried samples were re-suspended in PBS and taken to 
HPLC for analysis. Note that the corroles are present in the fast eluting fraction at about 
13 min, which represent much larger molecular weights. That fraction was absent when 
BSA was treated by the Protocol, but without any corrole derivative. 
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Figure S2. Spectra recorded for (A.) the HPLC-injected corrole/BSA conjugates at 
different retention times [(a) (2)Sb, (b) (2)Al, (c) (2)Ga,  (d) (2)Mn (e) (2)Fe,  (f) (2)Sn, 
(g) (2)H3]; and (B.) the same corrole in BSA-free DMSO solution Where are A and B? 
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Figure S3. Imaging of nanoparticles and estimation of size by different methods: (A) 
SEM images of (a) (2)Au/BSA isolated NP’s dried on silicon wafer, and (b) treated BSA 
after centrifugation dried on silicon wafer; (B) DLS distribution plot of isolated and re-
suspended in PBS (2)Au/BSA NP’s; (C) AFM images of (a) (2)Au/BSA isolated NP’s 
dried on silicon wafer, and (b) estimation of particles distance from silicone surface. 
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Figure S4. Solubility of formulated biconjugated corrole NP’s is indicated in the image 
above dissolved in PBS pH 7.2 next to the respective NP’s in solid form. The corrole 
BSA bioconjugated NP’s are readily soluble in water or buffer (up to 40mg/ml). In 
contrast TPFC with any metal at its core is highly lipophilic and not soluble in water or 
buffer (<10
-7
 mg/ml). 
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Figure S5. CD spectra of the different corrole NP’s: (a.) (2)Al, (b.) (2)Au, (c.) control (i. 
e. treated BSA), (d.) (2)H3 (free base), (e.) (2)Fe, (f.) (2)Ga, (g.) (2)Mn, (h.) (2)Sb and (i.) 
(2)Sn.  All other than the control BSA display signals in the visible region, implying 
interaction between protein and corrole (induced chirality).   
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Figure S6.  (2)Al  conjugated to BSA NPs in PBS after extraction. Particles were treated 
with Triton-X 2%. Triton-X facilitated extraction of corrole from PBS into DCM, shown 
at different times: a.) 30 sec, b.)1 min and c.) 4 min. DCM fraction was taken directly to 
run a column using DCM only as an eluent. (2)Al was stuck on the top of the column 
while most unwanted byproducts (e.g., triton-X) were washed down the column. After a 
few washes with pure DCM, DCM with a few drops of pyridine was added to the column 
for elution of (2)Al. Eluent was evaporated under vacuum and redissolved in C6D6 for 
NMR measurements. 
 
 
 
 
(a) (b) (c)(A)
Figure S7.  (a) 
19
F NMR in D2O (400Mhz) of (2)Al/BSA NP’s, (b) 
19
F NMR of (2)Al after extraction from NP’s 
(200MHz, in C6D6) and (c) 
1
H NMR of (2)Al after extraction from NP’s (200MHz, in C6D6). 
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Figure S8. MALDI-mass spec of (2)Ga BSA NP’s: (a)  control (i. e. BSA treated with 
DMSO without any corrole), (b) (2)Ga with BSA NP’s, and (c) low region mass spec of 
(2)Ga with BSA NP’s. 
 
Figure S9.  Quenching of the fluorescence of (2)Ga upon encapsulation in albumin based 
NP’s as detected by dissolving (2)Ga in DMSO to equal absorbance at 420 nm (largely 
different concentrations) of dialyzed NP’s in PBS. Florescence efficiency of detection 
declines to about 12.6% relative to monomeric (2)Ga in DMSO. Estimation of quantum 
yield of the Np’s is 0.048.   
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Figure S10.  (A) Chromatograms for detection of apo-transferrin (TF) and the corroles in 
apo-transferrin/corrole conjugates, with the reading set at 280 nm for detection of apo-
transferrin (blue line) and at 420 nm for detection of the corroles (red line): (a) apo-
transferrin only, (b) (2)Ga, (c) (2)Sn, (d) (2)Mn and (e) (2)Au; (B) DLS analysis of 
(2)Au/TF NP’s, size of observed particles was 173.3 ± 64.09 nm;   
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Figure S11.  Particle size distribution as analyzed from 12 separate fields in two distinct 
samples of (2)Au/HSA NPs (imaged using Cryo-TEM). 
 
 
 
 
Table S1.  IC50 values of (2)M series in DMSO(aq.) 0.1% recorded for different cancer 
cell lines.   
 (2)Ga (2)Au (2)Sb (2)Fe (2)Mn (2)Al 
DU145 156.6 > 400 > 400 297.9 > 400 > 400 
SK-MEL-28 171.5 > 400 > 400 116.4 > 400 > 400 
MDA-MB-
231 
177.1 > 400 296.5 115.7 129.1 > 400 
OVCAR-3 110.5 > 400 > 400 352.6 > 400 > 400 
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Table S2.  Asymmetric oxidation of thioanisole by H2O2 in solutions that contained 
either HSA, BSA, or NPs composed of HSA/BSA with Fe(III)/Mn(III)corroles. 
 
 
Catalyst
Albumin source
yield %; major enantiomer; ee %
HSA BSA
HSA-blank 12; R; 1 -
BSA-blank - 4; R; 1
(2)Mn 13; R; 11 77; R; 7
(2)Mn 21; R; 2; -
(2)Mn 1; R; 2 -
(2)Fe 70; R; 15 96; R; 1
(2)Fe 4; R; 1 -
(2)Fe 14; R; 16 -
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Figure S12.  HPLC traces of human serum incubated with the corresponding corroles 
(1)H3 (a & b) and the corresponding (1)Au (c & d), (1)Al (e & f), (1)Sb (g & h), (1)Mn (i 
& j), (1)Fe (k & l), (1)Ga (m & n) complexes, together with UV-vis spectra of the eluted 
fractions. The green and blue traces are chromatograms obtained by following changes at 
280 nm (to determine protein elution) and at the λmax of the eluting corrole (about 420 
nm), respectively. 
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Figure S13.  Cytotoxicity graphs of (1)M series (M = a) Sb, b) Al, c) Mn, d) Fe, e) Au, f) 
Ga, against four NCI-60 human cancer cell lines. 
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Figure S14.  Percentage binding affinity of (1)M to VLDL versus cytotoxicity for each 
of the four cell lines studied – a) DU145, b) SK-MEL-28, c) MDA-MB-231, and d) 
OVCAR-3. For each plot, each data point corresponds to (1)M. The data were fitted with 
a linear function. 
 
 
